Early Alzheimer’s Disease: Developing Drugs for Treatment Guidance for Industry
Docket Number: FDA-2013-D-0077 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research The purpose of this guidance is to assist sponsors in the clinical development of drugs for the treatment of the stages of sporadic Alzheimer’s …